20 research outputs found

    Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

    Get PDF
    Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed the efficacy and safety of treatment with docetaxel plus either ramucirumab-a human IgG1 VEGFR-2 antagonist-or placebo in this patient population

    Udviklingslinier i Oekonometrien

    No full text
    Recent Developments in Econometrics (In Danish) survey and assess the developments within econometric theory, microeconometrics, time series econometrics, financial econometrics, and latent variables.Econometrics
    corecore